COVER FE ATURE
ADVANCED IMMUNOTHERAPY TREATMENT
FOR LYMPHOMA AND LEUKEMIA GAINS
GROUND AT PENN STATE CANCER INSTITUTE 06
Chimeric antigen receptor (CAR) T-cell therapy helps
patients with treatment-resistant cancer live longer — and
research shows benefits of such therapy may extend beyond
cancer care.
FE ATURES
STUDY SHEDS LIGHT ON DIABETES
DURATION'S EFFECT ON CANCER RISK 05
Researchers explore the nuances between Type 2 diabetes
and cancer risk. Cancer risk tends to pea k less than a decade
following diagnosis, possibly related to insulin levels.
BOOSTING OUTCOMES FOR HEAD
AND NECK CANCERS 09
Patients with head and neck cancers benefit as Penn State
Hea lth becomes the first in the region to employ the da
Vinci SP.
06
contents
ON THE COVER
/////// OCTOBER 2022
NATIONAL FE ATURE
HEALTHCARE SECURITY:
RANSOMWARE ATTACKS ON THE RISE 12
Attacks in which hackers encrypt data until users pay a
ransom can cost millions of dollars and, more crucia lly,
disrupt medica l care. Adopting careful mitigation plans can
reduce the damage caused by a ransomware attack.
SPECIAL CLINICAL SECTION: ONCOLOGY
THE CONVERSATION AROUND DE-ESCALATION
IN BREAST CANCER SURGERY 14
Research shows aggressive surgica l treatment does not
a lways correlate with surviva l benefits in breast cancer
patients. Oncologic surgeons discuss how therapeutic
recommendations are changing.
05
09
